Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypertensive disease
|
1085 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.100 | 0.842 | 38 | 1998 | 2020 | |||||
Essential Hypertension
|
293 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.100 | 0.947 | 19 | 1997 | 2017 | |||||
Arteriosclerosis
|
267 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.040 | 1.000 | 4 | 2001 | 2020 | |||||
Atherosclerosis
|
281 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.040 | 1.000 | 4 | 2001 | 2020 | |||||
Cerebrovascular accident
|
591 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.030 | 1.000 | 3 | 2001 | 2008 | |||||
IGA Glomerulonephritis
|
130 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.030 | 1.000 | 3 | 2003 | 2014 | |||||
Myocardial Infarction
|
680 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.030 | 1.000 | 3 | 2006 | 2009 | |||||
Cardiovascular Diseases
|
711 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 1.000 | 2 | 2002 | 2006 | |||||
Chronic kidney disease stage 5
|
194 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 0.500 | 2 | 2003 | 2003 | |||||
Coronary heart disease
|
1178 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 1.000 | 2 | 2002 | 2007 | |||||
Gastroschisis
|
8 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 1.000 | 2 | 2006 | 2018 | |||||
Kidney Failure, Chronic
|
425 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 0.500 | 2 | 2003 | 2003 | |||||
Polycystic Kidney, Autosomal Dominant
|
35 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.020 | 1.000 | 2 | 2003 | 2003 | |||||
Cerebrovascular Disorders
|
56 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Coronary Arteriosclerosis
|
440 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Coronary Artery Disease
|
1577 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Endolymphatic Hydrops
|
1 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Endothelial dysfunction
|
25 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Hyperlipidemia, Familial Combined
|
28 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||
Hypernatremia
|
3 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Kidney Failure
|
36 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Meniere Disease
|
36 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Obesity
|
1111 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Peripheral Arterial Diseases
|
128 | 0.683 | 0.400 | 4 | 2904980 | missense variant | G/A;T | snv | 1.2E-05; 0.20 | 0.010 | 1.000 | 1 | 2002 | 2002 |